Hudson Bay Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-235,000
Closed -$102K 1091
2022
Q4
$102K Sell
235,000
-1,445,536
-86% -$629K ﹤0.01% 711
2022
Q3
$471K Hold
1,680,536
﹤0.01% 859
2022
Q2
$605K Sell
1,680,536
-1,464
-0.1% -$527 ﹤0.01% 923
2022
Q1
$1.13M Sell
1,682,000
-118,000
-7% -$79.1K 0.02% 782
2021
Q4
$2.32M Buy
1,800,000
+195,000
+12% +$252K 0.02% 625
2021
Q3
$3.48M Buy
1,605,000
+65,000
+4% +$141K 0.05% 460
2021
Q2
$4.2M Sell
1,540,000
-60,000
-4% -$164K 0.05% 390
2021
Q1
$4.18M Hold
1,600,000
0.05% 342
2020
Q4
$4.45M Buy
1,600,000
+275,000
+21% +$765K 0.05% 244
2020
Q3
$6.12M Sell
1,325,000
-350,000
-21% -$1.62M 0.09% 187
2020
Q2
$4.72M Buy
1,675,000
+325,000
+24% +$916K 0.08% 194
2020
Q1
$3.29M Buy
1,350,000
+756,784
+128% +$1.85M 0.08% 195
2019
Q4
$3.04M Buy
593,216
+98,216
+20% +$503K 0.07% 221
2019
Q3
$3.2M Sell
495,000
-55,000
-10% -$355K 0.09% 197
2019
Q2
$3.43M Buy
550,000
+384,375
+232% +$2.4M 0.08% 197
2019
Q1
$1.76M Buy
165,625
+9,375
+6% +$99.7K 0.02% 287
2018
Q4
$1.25M Buy
156,250
+30,000
+24% +$239K 0.02% 330
2018
Q3
$2.44M Buy
126,250
+29,762
+31% +$576K 0.03% 249
2018
Q2
$1.74M Buy
96,488
+24,613
+34% +$445K 0.02% 302
2018
Q1
$765K Buy
71,875
+28,125
+64% +$299K 0.02% 348
2017
Q4
$1.85M Buy
+43,750
New +$1.85M 0.04% 229
2017
Q2
Sell
-3,125
Closed -$374K 575
2017
Q1
$374K Buy
+3,125
New +$374K 0.01% 358
2015
Q3
Sell
-2,500
Closed -$408K 218
2015
Q2
$408K Buy
+2,500
New +$408K 0.01% 133